Holen Sie sich die Stockscreener-App
3.79
7.11%
-0.29
Handel nachbörslich:
3.80
0.010
+0.26%
Schlusskurs vom Vortag:
$4.08
Offen:
$4.07
24-Stunden-Volumen:
700.80K
Relative Volume:
1.50
Marktkapitalisierung:
$128.89M
Einnahmen:
$160.43M
Nettoeinkommen (Verlust:
$-227.64M
KGV:
-0.0551
EPS:
-68.77
Netto-Cashflow:
$-170.79M
1W Leistung:
-3.56%
1M Leistung:
-14.45%
6M Leistung:
-21.37%
1J Leistung:
+23.05%
1-Tages-Spanne:
$3.785
$4.07
1-Wochen-Bereich:
$3.785
$4.125
52-Wochen-Spanne:
$1.38
$7.34
Agenus Inc Stock (AGEN) Company Profile
Firmenname
Agenus Inc
Sektor
Branche
Telefon
781-674-4410
Adresse
3 FORBES ROAD, LEXINGTON, MA
Vergleichen Sie AGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AGEN
Agenus Inc
|
3.79 | 138.75M | 160.43M | -227.64M | -170.79M | -68.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Agenus Inc Stock (AGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-04 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2024-07-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2024-07-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-07-18 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-06 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-09-28 | Eingeleitet | SMBC Nikko | Outperform |
| 2021-12-16 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-11-19 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-04-22 | Eingeleitet | B. Riley FBR | Buy |
| 2016-10-28 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2016-10-27 | Bestätigt | Maxim Group | Buy |
| 2016-03-11 | Hochstufung | Maxim Group | Hold → Buy |
| 2015-12-16 | Eingeleitet | Jefferies | Buy |
| 2015-10-27 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-07-27 | Bestätigt | MLV & Co | Buy |
| 2015-06-11 | Eingeleitet | Oppenheimer | Outperform |
| 2015-01-12 | Bestätigt | Maxim Group | Buy |
| 2015-01-09 | Bestätigt | MLV & Co | Buy |
| 2015-01-09 | Bestätigt | Maxim Group | Buy |
| 2014-12-19 | Bestätigt | Maxim Group | Buy |
| 2014-05-08 | Bestätigt | Maxim Group | Buy |
| 2014-03-14 | Bestätigt | MLV & Co | Buy |
| 2013-10-08 | Bestätigt | Maxim Group | Buy |
| 2012-01-05 | Eingeleitet | William Blair | Outperform |
| 2011-12-01 | Eingeleitet | Global Hunter Securities | Buy |
Alle ansehen
Agenus Inc Aktie (AGEN) Neueste Nachrichten
BOT/BAL Shows Response in Undifferentiated Pleiomorphic Sarcoma – Agenus - Oncodaily
Is Agenus Inc. (AJ8) stock testing key supportEarnings Miss & Daily Technical Stock Forecast Reports - Newser
Will Agenus Inc. (AJ8) stock sustain bullish trend into 2025Trade Risk Report & Free High Return Stock Watch Alerts - Newser
Agenus accelerates global access with BATTMAN update - Traders Union
Why Agenus Inc. (AJ8) stock fits value portfoliosBull Run & Stock Timing and Entry Methods - Newser
Transcript : Agenus Inc.Shareholder/Analyst Call - MarketScreener
Will Agenus Inc. (AJ8) stock top growth indexesRate Cut & Verified Momentum Stock Ideas - Newser
Agenus (AGEN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Can Agenus Inc. stock rebound after recent weaknessJuly 2025 Weekly Recap & High Accuracy Investment Signals - Newser
Agenus Inc Stock Analysis and ForecastShort Selling Opportunities & Build Balanced Portfolio - earlytimes.in
What drives Agenus Inc AJ8 stock priceRelative Strength Index (RSI) & Superior Capital Appreciation - earlytimes.in
Free cash flow per share of Agenus Inc. – TRADEGATE:AJ8 - TradingView
Will Agenus Inc. (AJ8) stock outperform energy sector in 2025July 2025 Decliners & Reliable Volume Spike Trade Alerts - newser.com
Candlestick signals on Agenus Inc. stock today2025 Sector Review & Community Consensus Trade Alerts - newser.com
Can Agenus Inc. stock beat analyst upgradesLong Setup & Real-Time Buy Signal Notifications - newser.com
Forecasting Agenus Inc. price range with options dataEarnings Growth Summary & Technical Pattern Based Buy Signals - newser.com
Is Agenus Inc. (AJ8) stock a top dividend aristocrat candidatePortfolio Profit Report & Breakout Confirmation Alerts - newser.com
Agenus to Host End-of-Year Stakeholder Webcast Featuring GI Oncology Leaders and Progress of BOT/BAL - BioSpace
Is Agenus Inc. stock a safe buy before earningsLong Setup & Real-Time Volume Spike Alerts - newser.com
Is Agenus Inc. stock dividend yield sustainableSell Signal & AI Enhanced Trade Execution Alerts - newser.com
Using AI based signals to follow Agenus Inc.Insider Buying & Free Technical Pattern Based Buy Signals - newser.com
Is Agenus Inc. stock supported by innovation pipelineJuly 2025 Momentum & Weekly Stock Performance Updates - newser.com
Agenus (NASDAQ: AGEN) 2025 Webcast to Highlight Phase 3 BATTMAN BOT/BAL CRC Study - Stock Titan
Will Agenus Inc. (AJ8) stock see insider accumulationMarket Sentiment Summary & Fast Moving Stock Trade Plans - newser.com
Is Agenus Inc. stock poised for growthLayoff News & Smart Investment Allocation Insights - newser.com
How Agenus Inc. (AJ8) stock responds to bond marketStock Surge & Safe Swing Trade Setup Alerts - newser.com
Using R and stats models for Agenus Inc. forecastingWeekly Risk Report & High Conviction Trade Alerts - newser.com
How buyback programs support Agenus Inc. (AJ8) stock2025 Price Targets & Long-Term Capital Growth Strategies - newser.com
Agenus Appoints Dr. José Iglesias as Chief Medical Affairs Officer to Guide Global Medical Affairs and Early-Access Programs, Including France’s AAC - BioSpace
Finanzdaten der Agenus Inc-Aktie (AGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):